Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Gut. 2023 Nov 24;72(12):2321-2328. doi: 10.1136/gutjnl-2022-326970.
The natural history of small polyps is not well established and rests on limited evidence from barium enema studies decades ago. Patients with one or two small polyps (6-9 mm) at screening CT colonography (CTC) are offered CTC surveillance at 3 years but may elect immediate colonoscopy. This practice allows direct observation of the growth of subcentimetre polyps, with histopathological correlation in patients undergoing subsequent polypectomy.
Of 11 165 asymptomatic patients screened by CTC over a period of 16.4 years, 1067 had one or two 6-9 mm polyps detected (with no polyps ≥10 mm). Of these, 314 (mean age, 57.4 years; M:F, 141:173; 375 total polyps) elected immediate colonoscopic polypectomy, and 382 (mean age 57.0 years; M:F, 217:165; 481 total polyps) elected CTC surveillance over a mean of 4.7 years. Volumetric polyp growth was analysed, with histopathological correlation for resected polyps. Polyp growth and regression were defined as volume change of ±20% per year, with rapid growth defined as +100% per year (annual volume doubling). Regression analysis was performed to evaluate predictors of advanced histology, defined as the presence of cancer, high-grade dysplasia (HGD) or villous components.
Of the 314 patients who underwent immediate polypectomy, 67.8% (213/314) harboured adenomas, 2.2% (7/314) with advanced histology; no polyps contained cancer or HGD. Of 382 patients who underwent CTC surveillance, 24.9% (95/382) had polyps that grew, while 62.0% (237/382) remained stable and 13.1% (50/382) regressed in size. Of the 58.6% (224/382) CTC surveillance patients who ultimately underwent colonoscopic resection, 87.1% (195/224) harboured adenomas, 12.9% (29/224) with advanced histology. Of CTC surveillance patients with growing polyps who underwent resection, 23.2% (19/82) harboured advanced histology vs 7.0% (10/142) with stable or regressing polyps (OR: 4.0; p<0.001), with even greater risk of advanced histology in those with rapid growth (63.6%, 14/22, OR: 25.4; p<0.001). Polyp growth, but not patient age/sex or polyp morphology/location were significant predictors of advanced histology.
Small 6-9 mm polyps present overall low risk to patients, with polyp growth strongly associated with higher risk lesions. Most patients (75%) with small 6-9 mm polyps will see polyp stability or regression, with advanced histology seen in only 7%. The minority of patients (25%) with small polyps that do grow have a 3-fold increased risk of advanced histology.
小型息肉的自然史尚未得到充分证实,其依据是几十年前钡剂灌肠研究的有限证据。在 CT 结肠成像(CTC)筛查中发现 1 或 2 个直径为 6-9 毫米的小息肉的患者,可在 3 年内接受 CTC 监测,但也可选择立即行结肠镜检查。这种做法允许直接观察亚厘米大小息肉的生长,并在随后行息肉切除术的患者中进行组织病理学相关性观察。
在 16.4 年的时间内,对 11165 名无症状患者进行了 CTC 筛查,其中 1067 名患者发现 1 或 2 个直径为 6-9 毫米的息肉(无直径≥10 毫米的息肉)。其中,314 名患者(平均年龄 57.4 岁;男:女,141:173;375 个总息肉)选择立即行结肠镜息肉切除术,382 名患者(平均年龄 57.0 岁;男:女,217:165;481 个总息肉)选择在平均 4.7 年内进行 CTC 监测。分析了息肉体积的生长情况,并对切除的息肉进行了组织病理学相关性分析。息肉生长和消退定义为每年体积变化±20%,快速生长定义为每年体积增加 100%(每年体积翻倍)。进行回归分析以评估高级别组织学(定义为存在癌症、高级别异型增生(HGD)或绒毛成分)的预测因子。
在 314 名立即行息肉切除术的患者中,67.8%(213/314)患者存在腺瘤,2.2%(7/314)患者存在高级别组织学;无息肉含有癌症或 HGD。在 382 名接受 CTC 监测的患者中,24.9%(95/382)的息肉生长,而 62.0%(237/382)稳定,13.1%(50/382)缩小。在最终接受结肠镜切除术的 382 名 CTC 监测患者中,58.6%(224/382)的患者有息肉生长,其中 87.1%(195/224)存在腺瘤,12.9%(29/224)存在高级别组织学。在接受切除术的有生长息肉的 CTC 监测患者中,23.2%(19/82)存在高级别组织学,而稳定或消退息肉患者为 7.0%(10/142)(OR:4.0;p<0.001),快速生长的患者中高级别组织学的风险更高(63.6%,14/22,OR:25.4;p<0.001)。息肉生长是高级别组织学的重要预测因子,而不是患者年龄/性别或息肉形态/位置。
直径为 6-9 毫米的小息肉总体上对患者风险较低,息肉生长与高风险病变密切相关。大多数(75%)直径为 6-9 毫米的小息肉患者的息肉会稳定或消退,只有 7%的患者会出现高级别组织学。极少数(25%)有生长的小息肉患者有 3 倍的高级别组织学风险。